ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:LLY • US5324571083

927.5 EUR
+53.3 (+6.1%)
Last: Feb 4, 2026, 05:28 PM
Fundamental Rating

6

LLY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While LLY has a great profitability rating, there are some minor concerns on its financial health. LLY shows excellent growth, but is valued quite expensive already. These ratings would make LLY suitable for growth investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • LLY had positive earnings in the past year.
  • In the past year LLY had a positive cash flow from operations.
  • In the past 5 years LLY has always been profitable.
  • In the past 5 years LLY always reported a positive cash flow from operatings.
LLY.DE Yearly Net Income VS EBIT VS OCF VS FCFLLY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • LLY has a Return On Assets of 16.02%. This is amongst the best in the industry. LLY outperforms 89.09% of its industry peers.
  • LLY has a Return On Equity of 77.38%. This is amongst the best in the industry. LLY outperforms 96.36% of its industry peers.
  • LLY has a better Return On Invested Capital (28.84%) than 94.55% of its industry peers.
  • LLY had an Average Return On Invested Capital over the past 3 years of 21.71%. This is significantly above the industry average of 14.23%.
  • The 3 year average ROIC (21.71%) for LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.84%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
LLY.DE Yearly ROA, ROE, ROICLLY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

  • With an excellent Profit Margin value of 30.99%, LLY belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
  • LLY's Profit Margin has declined in the last couple of years.
  • The Operating Margin of LLY (44.41%) is better than 96.36% of its industry peers.
  • LLY's Operating Margin has improved in the last couple of years.
  • LLY has a Gross Margin of 83.03%. This is amongst the best in the industry. LLY outperforms 83.64% of its industry peers.
  • In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
LLY.DE Yearly Profit, Operating, Gross MarginsLLY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LLY is creating value.
  • Compared to 1 year ago, LLY has about the same amount of shares outstanding.
  • LLY has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for LLY is higher compared to a year ago.
LLY.DE Yearly Shares OutstandingLLY.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY.DE Yearly Total Debt VS Total AssetsLLY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 8.20 indicates that LLY is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 8.20, LLY belongs to the top of the industry, outperforming 92.73% of the companies in the same industry.
  • The Debt to FCF ratio of LLY is 6.60, which is on the high side as it means it would take LLY, 6.60 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LLY (6.60) is worse than 60.00% of its industry peers.
  • LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
  • LLY's Debt to Equity ratio of 1.72 is on the low side compared to the rest of the industry. LLY is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.2
ROIC/WACC3.06
WACC9.41%
LLY.DE Yearly LT Debt VS Equity VS FCFLLY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • LLY has a Current ratio (1.55) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
  • LLY's Quick ratio of 1.24 is fine compared to the rest of the industry. LLY outperforms 67.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY.DE Yearly Current Assets VS Current LiabilitesLLY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

8

3. Growth

3.1 Past

  • LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.22%, which is quite impressive.
  • The Earnings Per Share has been growing by 16.57% on average over the past years. This is quite good.
  • Looking at the last year, LLY shows a very strong growth in Revenue. The Revenue has grown by 45.41%.
  • LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%

3.2 Future

  • Based on estimates for the next years, LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.61% on average per year.
  • The Revenue is expected to grow by 19.64% on average over the next years. This is quite good.
EPS Next Y84.93%
EPS Next 2Y59.63%
EPS Next 3Y46.9%
EPS Next 5Y32.61%
Revenue Next Year41.38%
Revenue Next 2Y31.01%
Revenue Next 3Y26.06%
Revenue Next 5Y19.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LLY.DE Yearly Revenue VS EstimatesLLY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
LLY.DE Yearly EPS VS EstimatesLLY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

3

4. Valuation

4.1 Price/Earnings Ratio

  • LLY is valuated quite expensively with a Price/Earnings ratio of 49.79.
  • Compared to the rest of the industry, the Price/Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 69.09% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.18. LLY is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 33.04 indicates a quite expensive valuation of LLY.
  • 70.91% of the companies in the same industry are cheaper than LLY, based on the Price/Forward Earnings ratio.
  • LLY is valuated rather expensively when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 49.79
Fwd PE 33.04
LLY.DE Price Earnings VS Forward Price EarningsLLY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 69.09% of the companies in the same industry are cheaper than LLY, based on the Enterprise Value to EBITDA ratio.
  • 67.27% of the companies in the same industry are cheaper than LLY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 160.77
EV/EBITDA 35.63
LLY.DE Per share dataLLY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of LLY may justify a higher PE ratio.
  • LLY's earnings are expected to grow with 46.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.59
PEG (5Y)3
EPS Next 2Y59.63%
EPS Next 3Y46.9%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.68%, LLY is not a good candidate for dividend investing.
  • LLY's Dividend Yield is comparable with the industry average which is at 1.95.
  • With a Dividend Yield of 0.68, LLY pays less dividend than the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • The dividend of LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
LLY.DE Yearly Dividends per shareLLY.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
  • LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y59.63%
EPS Next 3Y46.9%
LLY.DE Yearly Income VS Free CF VS DividendLLY.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B 10B
LLY.DE Dividend Payout.LLY.DE Dividend Payout, showing the Payout Ratio.LLY.DE Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

FRA:LLY (2/4/2026, 5:28:01 PM)

927.5

+53.3 (+6.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-04
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap876.84B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts81.08
Price Target959.52 (3.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend4.14
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)2.03%
PT rev (3m)20.46%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)1.17%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)6.01%
Revenue NQ rev (1m)0.82%
Revenue NQ rev (3m)3.69%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)3.42%
Valuation
Industry RankSector Rank
PE 49.79
Fwd PE 33.04
P/S 17.41
P/FCF 160.77
P/OCF 64.42
P/B 43.49
P/tB 90.38
EV/EBITDA 35.63
EPS(TTM)18.63
EY2.01%
EPS(NY)28.07
Fwd EY3.03%
FCF(TTM)5.77
FCFY0.62%
OCF(TTM)14.4
OCFY1.55%
SpS53.26
BVpS21.33
TBVpS10.26
PEG (NY)0.59
PEG (5Y)3
Graham Number94.55
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.84%
ROICexc 33.25%
ROICexgc 41.06%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.2
F-Score7
WACC9.41%
ROIC/WACC3.06
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.93%
EPS Next 2Y59.63%
EPS Next 3Y46.9%
EPS Next 5Y32.61%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.38%
Revenue Next 2Y31.01%
Revenue Next 3Y26.06%
Revenue Next 5Y19.64%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.81%
EBIT Next 3Y47.2%
EBIT Next 5Y33.2%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%

ELI LILLY & CO / LLY.DE FAQ

Can you provide the ChartMill fundamental rating for ELI LILLY & CO?

ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.


What is the valuation status of ELI LILLY & CO (LLY.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for LLY stock?

The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY.DE) is 49.79 and the Price/Book (PB) ratio is 43.49.


What is the earnings growth outlook for ELI LILLY & CO?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 84.93% in the next year.